Conference item icon

Conference item

Discovery and quantitation of novel liver fibrosis biomarkers in hepatitis C patients

Abstract:
Liver biopsy is the reference standard for assessing liver fibrosis and no reliable serum biomarkers are available to discriminate between the intermediate stages of fibrosis. We used proteomics to identify novel fibrosis biomarkers in hepatitis C patients with different degrees of liver fibrosis.
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Publisher's version

Actions


Access Document


Files:
Publisher copy:
10.4172/2167-0889-C1-014

Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Biochemistry
Role:
Author
Publisher:
OMICS International Publisher's website
Volume:
6
Issue:
3
Pages:
50
Publication date:
2017-09-05
DOI:
Pubs id:
pubs:812626
URN:
uri:8ad1da2a-4c87-4bd1-97a7-e2c36717a2a7
UUID:
uuid:8ad1da2a-4c87-4bd1-97a7-e2c36717a2a7
Local pid:
pubs:812626

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP